REG4 contributes to the invasiveness of pancreatic cancer by upregulating MMP-7 and MMP-9

Cancer Science

Volumn 103, Issue 12, 2012, Pages 2082-2091

  He, Xu Jun ^a   Jiang, Xiao Ting ^b   Ma, Ying Yu ^a   Xia, Ying Jie ^a   Wang, Hui Ju ^a   Guan, Tian Pei ^c   Shao, Qin Shu ^b   Tao, Hou Quan ^a,b  

^a Key Laboratory of Gastroenterology of Zhejiang Province   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; GELATINASE B; MATRILYSIN; ONCOPROTEIN; REGENERATING GENE FAMILY MEMBER 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASSAY; CANCER CELL CULTURE; CANCER INVASION; CELL PROLIFERATION; CULTURE MEDIUM; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

CELL PROLIFERATION; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; MALE; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84870660245     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12018     Document Type: Article

References (32)

1. Hidalgo M. Pancreatic cancer. N Engl J Med 2010; 362: 1605-17.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
3. Hartupee JC, Zhang H, Bonaldo MF, Soares MB, Dieckgraefe BK. Isolation and characterization of a cDNA encoding a novel member of the human regenerating protein family: Reg IV. Biochim Biophys Acta 2001; 1518: 287-93.
4. Hayashi T, Matsubara A, Ohara S et al. Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker. Oncol Rep 2009; 21: 95-100.
5. Oue N, Hamai Y, Mitani Y et al. Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 2004; 64: 2397-405.
6. Oue N, Mitani Y, Aung PP et al. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol 2005; 207: 185-98.
7. Takayama R, Nakagawa H, Sawaki A et al. Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma. J Gastroenterol 45:52-9.
8. Tamura H, Ohtsuka M, Washiro M et al. Reg IV expression and clinicopathologic features of gallbladder carcinoma. Hum Pathol 2009; 40: 1686-92.
9. Violette S, Festor E, Pandrea-Vasile I et al. Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas. Int J Cancer 2003; 103: 185-93.
10. Oue N, Kuniyasu H, Noguchi T et al. Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high serum levels of Reg IV are associated with liver metastasis. Oncology 2007; 72: 371-80.
11. Oue N, Sentani K, Noguchi T et al. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int J Cancer 2009; 125: 2383-92.
12. Tao HQ, He XJ, Jiang XT, Ma YY, Wang HJ, Xia YJ. Significance of serum REG4 upregulation in the diagnosis and treatment of pancreatic adenocarinoma. J Surg Concepts Pract 2010;15: 522-5.
13. Rafa L, Dessein AF, Devisme L et al. REG4 acts as a mitogenic, motility and pro-invasive factor for colon cancer cells. Int J Oncol 2010; 36: 689-98.
14. Zhang Y, Lai M, Lv B et al. Overexpression of Reg IV in colorectal adenoma. Cancer Lett 2003; 200: 69-76.
15. Bishnupuri KS, Luo Q, Sainathan SK et al. Reg IV regulates normal intestinal and colorectal cancer cell susceptibility to radiation-induced apoptosis. Gastroenterology 2010; 138: 616-26.
16. Hu G, Shen J, Cheng L et al. Reg4 protects against acinar cell necrosis in experimental pancreatitis. Gut 2011; 60: 820-8.
17. Gu Z, Rubin MA, Yang Y et al. Reg IV: a promising marker of hormone refractory metastatic prostate cancer. Clin Cancer Res 2005; 11: 2237-43.
18. Tao HQ, He XJ, Ma YY et al. Evaluation of REG4 for early diagnosis and prognosis of gastric cancer. Hum Pathol 2011; 42: 1401-9.
19. Kuniyasu H, Oue N, Sasahira T et al. Reg IV enhances peritoneal metastasis in gastric carcinomas. Cell Prolif 2009; 42: 110-21.
20. Miyagawa K, Sakakura C, Nakashima S et al. Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as A novel marker for the detection of peritoneal micrometastasis. Anticancer Res 2008; 28: 1169-79.
21. Wang HJ, Ruan HJ, He XJ et al. MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 2010; 46: 2295-303.
22. Takehara A, Eguchi H, Ohigashi H et al. Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4. Cancer Sci 2006; 97: 1191-7.
23. Legoffic A, Calvo E, Cano C et al. The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target. PLoS ONE 2009; 4: e7495.
24. Sasahira T, Oue N, Kirita T et al. Reg IV expression is associated with cell growth and prognosis of adenoid cystic carcinoma in the salivary gland. Histopathology 2008; 53: 667-75.
25. Pryczynicz A, Guzinska-Ustymowicz K, Dymicka-Piekarska V, Czyzewska J, Kemona A. Expression of matrix metalloproteinase 9 in pancreatic ductal carcinoma is associated with tumor metastasis formation. Folia Histochem Cytobiol 2007; 45: 37-40.
26. Crawford HC, Scoggins CR, Washington MK, Matrisian LM, Leach SD. Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. J Clin Invest 2002; 109: 1437-44.
27. Nakamura H, Horita S, Senmaru N et al. Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma. Oncol Rep 2002; 9: 751-5.
28. Yamamoto H, Itoh F, Iku S et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression. J Clin Oncol 2001; 19: 1118-27.
29. Tan X, Egami H, Ishikawa S et al. Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer. Int J Oncol 2005; 26: 1283-9.
30. Matsuyama Y, Takao S, Aikou T. Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas. J Surg Oncol 2002; 80: 105-10.
31. Nagakawa Y, Aoki T, Kasuya K, Tsuchida A, Koyanagi Y. Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer. Pancreas 2002; 24: 169-78.
32. Bishnupuri KS, Luo Q, Murmu N, Houchen CW, Anant S, Dieckgraefe BK. Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas. Gastroenterology 2006; 130: 137-49.